Skip to menu Skip to content Skip to footer
Professor Mark Smithers
Professor

Mark Smithers

Email: 

Overview

Background

Emeritus Professor Mark Smithers is a surgical oncologist who specialises in surgery for oesophago-gastric diseases, melanoma, advanced skin cancer and soft tissue sarcoma. He was the Director of the Upper GI and Soft Tissue Unit at the Princess Alexandra Hospital, in Brisbane, Australia from 1998 - 2023. Commencing his academic career with the University of Queensland in 1987, he progressed to be the Mayne Chair in Surgery and head of the Academy of Surgery. He is the second University of Queensland Medical graduate to be appointed to this role. His research has been focussed on the development and assessment of outcomes from minimally invasive upper GI surgery, and trials assessing the role of perioperative multidisciplinary therapy for esophageal and gastric cancer. As well he has led, or been involved with, clinical trials from phase I to III, for all stages of melanoma through his role as the Chair of the Queensland Melanoma Project. More recently he has been involved with the assessment of access to, and outcomes from, surgery for cancer in Queensland, Australia.

He has overseen the administration and development of the surgery curriculum, and the teaching, in the Academy of Surgery, in the UQ Faculty of Medicine. He was on a number of committees relevant to the implementation of the UQ MD design course. He has held various leadership and committee roles with the Royal Australasian College of Surgeons, as well as leadership roles, including the Presidency, in the Australian and New Zealand Oesophago Gastric Surgeons Association. He has also been on the committees of international organisations related to oesophageal and gastric surgery. He has published 250 articles, eight book chapters, and has been on the editorial board of a number of surgical journals.

He has been recognised for his clinical and academic roles by the award of Member of the Order of Australia (AM). The citation reads, "for service to medicine in the fields of gastro-intestinal and melanoma surgery, to medical education and to professional organisations". The Royal Australasian College of Surgeons awarded him the Sir Hugh Devine medal, for services to surgery and the community. This is the College’s highest honour. Internationally, he has been awarded an honorary fellowship of the Royal College of Surgeons of Edinburgh and recently, in the United States, he was elected as an Honarary Fellow of the American Surgical Association.

Availability

Professor Mark Smithers is:
Not available for supervision
Media expert

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Honorary Fellow, American Surgical Association, American Surgical Association
  • Fellow, Royal Australasian College of Surgeons, Royal Australasian College of Surgeons
  • Fellow, Royal College of Surgeons of Edinburgh, Royal College of Surgeons of Edinburgh
  • Fellow, Royal College of Surgeons of England, Royal College of Surgeons of England

Research interests

  • Cutaneous Melanoma

    epidemiology, public health issues and management of all stages

  • Management of Oesophageal and Gastric Cancer

    Investigation and management of benign and malignant diseases of the oesophagus and the stomach.

Works

Search Professor Mark Smithers’s works on UQ eSpace

414 works between 1983 and 2025

81 - 100 of 414 works

2020

Journal Article

Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study

Beesley, Vanessa L., Hughes, Maria Celia B., Smithers, B. Mark, Khosrotehrani, Kiarash, Malt, Maryrose K., von Schuckmann, Lena A. and Green, Adèle C. (2020). Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study. Journal of Cancer Survivorship, 14 (5), 712-719. doi: 10.1007/s11764-020-00885-9

Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal study

2020

Journal Article

Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanoma

von Schuckmann, Lena A., Khosrotehrani, Kiarash, Hughes, Maria Celia B., van der Pols, Jolieke C., Malt, Maryrose, Smithers, B. Mark and Green, Adele C. (2020). Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanoma. Journal of the American Academy of Dermatology, 82 (6), 1521-1524. doi: 10.1016/j.jaad.2020.01.067

Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanoma

2020

Journal Article

Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis

Mahamat-Saleh, Yahya, Hughes, Maria Celia B., Miura, Kyoko, Malt, Maryrose K., von Schuckmann, Lena, Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adèle C. (2020). Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis. Cancer Epidemiology Biomarkers & Prevention, 29 (8), 1647-1653. doi: 10.1158/1055-9965.epi-20-0319

Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at Diagnosis

2020

Journal Article

Efficacy of immune checkpoint inhibitors for in-transit melanoma

Nan Tie, Emilia, Lai-Kwon, Julia, Rtshiladze, Michael Alexander, Na, Lumine, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V., McArthur, Grant A., Sandhu, Shahneen, Saw, Robyn, Walpole, Euan, Menzies, Alexander, Smithers, Mark and Gyorki, David E. (2020). Efficacy of immune checkpoint inhibitors for in-transit melanoma. Journal for Immunotherapy of Cancer, 8 (1) e000440, 1-6. doi: 10.1136/jitc-2019-000440

Efficacy of immune checkpoint inhibitors for in-transit melanoma

2020

Journal Article

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

Landi, Maria Teresa, GenoMEL Consortium, Bishop, D. Timothy, MacGregor, Stuart, Machiela, Mitchell J., Stratigos, Alexander J., Ghiorzo, Paola, Brossard, Myriam, Calista, Donato, Choi, Jiyeon, Fargnoli, Maria Concetta, Zhang, Tongwu, Rodolfo, Monica, Trower, Adam J., Menin, Chiara, Martinez, Jacobo, Hadjisavvas, Andreas, Song, Lei, Stefanaki, Irene, Scolyer, Richard, Yang, Rose, Goldstein, Alisa M., Potrony, Miriam, Kypreou, Katerina P., Pastorino, Lorenza, Queirolo, Paola, Pellegrini, Cristina, Cattaneo, Laura, Zawistowski, Matthew ... MelaNostrum Consortium (2020). Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nature Genetics, 52 (5), 494-504. doi: 10.1038/s41588-020-0611-8

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

2020

Journal Article

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

Cebon, Jonathan S., Gore, Martin, Thompson, John F., Davis, Ian D., McArthur, Grant A., Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P. Rod, MacGregor, Duncan, Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael P. N., Hersey, Peter, Evans, T. R. Jeffry, Ottensmeier, Christian Hermann, Marsden, Jeremy, Dalgleish, Angus G., Corrie, Pippa G., Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M., Endo-Munoz, Liliana, Tutuka, Candani S. A., Venhaus, Ralph, Old, Lloyd J. ... Chen, Weisan (2020). Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Journal for ImmunoTherapy of Cancer, 8 (1) e000410, e000410. doi: 10.1136/jitc-2019-000410

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

2020

Journal Article

Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant Imatinib

Gronchi, Alessandro, Bonvalot, Sylvie, Poveda Velasco, Andres, Kotasek, Dusan, Rutkowski, Piotr, Hohenberger, Peter, Fumagalli, Elena, Judson, Ian R., Italiano, Antoine, Gelderblom, Hans J., Van Coevorden, Frits, Penel, Nicolas, Kopp, Hans-Georg, Duffaud, Florence, Goldstein, David, Broto, Javier Martin, Wardelmann, Eva, Marréaud, Sandrine, Smithers, Mark, Le Cesne, Axel, Zaffaroni, Facundo, Litière, Saskia, Blay, Jean-Yves and Casali, Paolo G. (2020). Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant Imatinib. JAMA Surgery, 155 (6), e200397. doi: 10.1001/jamasurg.2020.0397

Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant Imatinib

2020

Journal Article

Systemic therapy for melanoma: ASCO guideline

Seth, Rahul, Messersmith, Hans, Kaur, Varinder, Kirkwood, John M., Kudchadkar, Ragini, McQuade, Jennifer Leigh, Provenzano, Anthony, Swami, Umang, Weber, Jeffrey, Alluri, Krishna C., Agarwala, Sanjiv, Ascierto, Paolo A., Atkins, Michael B., Davis, Nancy, Ernstoff, Marc S., Faries, Mark B., Gold, Jason S., Guild, Samantha, Gyorki, David E., Khushalani, Nikhil I., Meyers, Michael O., Robert, Caroline, Santinami, Mario, Sehdev, Amikar, Sondak, Vernon K., Spurrier, Gilliosa, Tsai, Katy K., van Akkooi, Alexander and Funchain, Pauline (2020). Systemic therapy for melanoma: ASCO guideline. Journal of Clinical Oncology, 38 (33), 1-27. doi: 10.1200/JCO.20.00198

Systemic therapy for melanoma: ASCO guideline

2020

Journal Article

Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study

Theile, Harrison, Moore, Julie, Dunn, Nathan, Cossio, Danica, Forristal, Catherine E., Green, Adele C. and Smithers, B. Mark (2020). Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study. ANZ Journal of Surgery, 90 (4) ans.15804, 503-507. doi: 10.1111/ans.15804

Regional nodal metastasis and 5-year survival in patients with thin melanoma in Queensland: a population-based study

2020

Journal Article

International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients

Teras, Jüri, Kroon, Hidde M., Miura, John T., Kenyon-Smith, Tim, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Carr, Michael, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Tyler, Douglas S., Coventry, Brendon J., Zager, Jonathan S. and Thompson, John F. (2020). International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients. Annals of Surgical Oncology, 27 (5), 1420-1429. doi: 10.1245/s10434-020-08312-0

International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients

2020

Journal Article

Statins may reduce disease recurrence in patients with ulcerated primary melanoma

von Schuckmann, L. A., Khosrotehrani, K., Ghiasvand, R., Hughes, M. C.B., van der Pols, J. C., Malt, M., Smithers, B. M. and Green, A. C. (2020). Statins may reduce disease recurrence in patients with ulcerated primary melanoma. British Journal of Dermatology, 183 (6), 1049-1055. doi: 10.1111/bjd.19012

Statins may reduce disease recurrence in patients with ulcerated primary melanoma

2020

Journal Article

Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial

Janda, Monika, Horsham, Caitlin, Vagenas, Dimitrios, Loescher, Lois J., Gillespie, Nicole, Koh, Uyen, Curiel-Lewandrowski, Clara, Hofmann-Wellenhof, Rainer, Halpern, Allan, Whiteman, David C., Whitty, Jennifer A., Smithers, B. Mark and Soyer, H. Peter (2020). Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial. The Lancet Digital Health, 2 (3), e129-e137. doi: 10.1016/S2589-7500(20)30001-7

Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial

2020

Journal Article

Long‐term deaths from melanoma according to tumour thickness at diagnosis

Baade, Peter D., Whiteman, David C., Janda, Monika, Cust, Anne E., Neale, Rachel E., Smithers, B. Mark, Green, Adele C., Khosrotehrani, Kiarash, Mar, Victoria, Soyer, H. Peter and Aitken, Joanne F. (2020). Long‐term deaths from melanoma according to tumour thickness at diagnosis. International Journal of Cancer, 147 (5) ijc.32930, 1391-1396. doi: 10.1002/ijc.32930

Long‐term deaths from melanoma according to tumour thickness at diagnosis

2020

Journal Article

Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls

Duffy, David L., Jagirdar, Kasturee, Lee, Katie J., McWhirter, Seamus R., McMeniman, Erin K., De’Ambrosis, Brian, Pflugfelder, Annette, Rayner, Jenna E., Whiteman, David C., Brown, Matthew A., Martin, N.G., Smithers, B.M., Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2020). Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls. Journal of Investigative Dermatology, 140 (2), 498-501.e17. doi: 10.1016/j.jid.2019.05.032

Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls

2020

Journal Article

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

Barbour, A. P., Walpole, E. T., Mai, G. T., Barnes, E. H., Watson, D. I., Ackland, S. P., Martin, J. M., Burge, M., Finch, R., Karapetis, C. S., Shannon, J., Nott, L. M., Varma, S., Marx, G., Falk, G. L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J. R., Simes, J., Smithers, B. M. and on behalf of the DOCTOR investigators (2020). Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. Annals of Oncology, 31 (2), 236-245. doi: 10.1016/j.annonc.2019.10.019

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

2020

Conference Publication

Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia

Sun, J., Kroon, H. M., Miura, J. T., Beasley, G. M., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Carr, M. J., Kirichenko, D., Potdar, A., Daou, H., Mullen, D., Farma, J. M., Henderson, M. A., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Thompson, J. F. and Zager, J. S. (2020). Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER.

Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia

2020

Conference Publication

Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy Alone

Crystal, J., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Agnese, D., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K. M. ... Faries, M. B. (2020). Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy Alone. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER.

Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy Alone

2020

Conference Publication

The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-II

Garland-Kledzik, M., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K., Gesierich, A. ... Faries, M. B. (2020). The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-II. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER.

The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-II

2020

Conference Publication

Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center Analysis

Kroon, H. M., Kenyon-Smith, T., Miura, J. T., Teras, J., Beasley, G. M., Mullen, D., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Potdar, A., Daou, H., Sun, J., Farma, J. M., Henderson, M. A., Speakman, D., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Zager, J. S. and Thompson, J. F. (2020). Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center Analysis. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER.

Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center Analysis

2020

Conference Publication

Highlights of the 2019 Annual Academic Surgery Conference

Di Bella, Claudia, Lee, James C., Koh, Cherry E., Mukherjee, Payal and Smithers, Mark (2020). Highlights of the 2019 Annual Academic Surgery Conference. 2019 Annual Academic Surgery Conference, Melbourne, VIC, Australia, 7-8 November 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ans.15713

Highlights of the 2019 Annual Academic Surgery Conference

Funding

Current funding

  • 2024 - 2025
    Optimising the Diagnosis and Management of Unilateral Primary Aldosteronism (MSH SERTA Grant led by Metro South HHS)
    Metro South Hospital and Health Service
    Open grant
  • 2023 - 2026
    iCare - An interactive online portal to improve health and wellbeing for people living with complex cancers, and their informal carers: a Phase II randomised controlled trial (Ex led Deakin MRFF CTA)
    Deakin University
    Open grant
  • 2021 - 2026
    AGITG TOP GEAR: A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer (CTCS: led by USyd)
    University of Sydney
    Open grant
  • 2019 - 2026
    A Randomised Phase II Trial of Adjuvant Avelumab in Patients with Early Stage Merkel Cell Carcinoma
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2025
    Melanoma Margins Trial II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins.. (NHMRC Project Grant led by the University of Melbourne).
    University of Melbourne
    Open grant

Past funding

  • 2021 - 2024
    Advanced technological approach to predicting survival in patients diagnosed with locally invasive cutaneous melanoma
    Cancer Council Queensland
    Open grant
  • 2021 - 2024
    Establishing Australia's First Familial Melanoma Clinic (MSH RSS SERTA Program Grant led by Metro South Hospital and Health Service)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Cancer Evolution Biobank
    PA Research Foundation
    Open grant
  • 2017 - 2019
    Predictors of mortality in thin melanomas
    Cancer Council Queensland
    Open grant
  • 2013 - 2015
    To identify and assess markers of prognosis, response and resistance to therapy in patients with Stage III metastatic melanoma
    Cancer Bequest Fund
    Open grant
  • 2011
    DOCetaxel with or without radiation Therapy for resectable Oesophageal adenocarcinoma based on early PET Response to induction chemotherapy (DOCTOR)
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Effects of nevogenesis susceptibility genes and phenotypic correlation with dermoscopic characteristics of nevi
    NHMRC Project Grant
    Open grant
  • 2010 - 2014
    Comparison of pre- and perioperative immunonutrition in patients undergoing surgical resection of oesophageal cancer (NHMRC Project Grant administered by the University of Adelaide)
    University of Adelaide
    Open grant
  • 2001 - 2002
    The epidemiology of oesophageal cancer: Risk and molecular markers
    Queensland Cancer Fund
    Open grant
  • 2000
    The role of TAP and MHC class I expression in the response to melanoma immunotherapy using autologous dendritic cells
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1999 - 2000
    A phase II clinical trial in patients with metastatic melanoma comparing autologous dendritic cells pulsed with autologous tumour peptides and melanoma associated peptides linked to the endoplasmic re
    Queensland Cancer Fund
    Open grant
  • 1998
    A Phase I/II Clinical Trial to Test Tumour Vaccines Comprising with Protein or Autologous Tumour Antigen Autologous Dandritic Cells Generated in a Closed Bag System Pulsed
    Mayne Bequest Fund
    Open grant
  • 1998
    Isolated limb infusion of melphalan and microdialysis technique in treatment of recurrent malignant melanoma
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1998 - 2000
    Treatment of Recurrent Malignant Melanoma by Limb Infusion of Cytotoxic Drugs and Other Techniques
    NHMRC Project Grant
    Open grant
  • 1997 - 1998
    Pharmacokinetics of tumour necrosis factor (TNF) in isolated rat hindlimb perfusions and infusions related to melanoma therapy
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1996 - 1997
    Targeting and monitoring drug delivery in specific tissues using iontophoresis and microdialysis
    Quality Funds Round 3
    Open grant
  • 1995 - 1997
    Pharmacokinetics of melphalan in isolated limb perfusion and infusion
    Queensland Cancer Fund
    Open grant

Supervision

Availability

Professor Mark Smithers is:
Not available for supervision

Supervision history

Current supervision

  • Master Philosophy

    Assessment of the impact of treating service characteristics on surgical and oncological outcomes for patients with Retroperitoneal and Inguinal Sarcomas in Queensland

    Principal Advisor

    Other advisors: Professor Andrew Barbour

  • Master Philosophy

    Factors Influencing Anastomotic Complications after Oesophagectomy

    Associate Advisor

  • Doctor Philosophy

    New tools for the multi-modal evaluation of pancreatic cancer and its precursor neoplasms.

    Associate Advisor

    Other advisors: Dr David Cavallucci

Completed supervision

Media

Enquiries

Contact Professor Mark Smithers directly for media enquiries about:

  • Advanced endoscopic surgery
  • Cancer surgery
  • Endoscopic surgery
  • General surgery
  • Melanoma
  • Surgery - cancer
  • Surgery - oesophageal, gastric cancer
  • Surgery - upper GI
  • Upper GI surgery

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au